Kyverna Therapeutics与Jefferies签订公开市场销售协议 日期为2025年3月27日——SEC文件披露

美股速递
Apr 03

根据一份日期为2025年3月27日提交至美国证券交易委员会(SEC)的文件显示,Kyverna Therapeutics Inc(股票代码:KYTX)已与Jefferies LLC正式签署了一项公开市场销售协议。

该协议的签订意味着Kyverna Therapeutics已授权Jefferies作为其销售代理,未来可在公开市场上根据市场条件,按公司指示的价格和数量出售其普通股股份。此类安排通常为公司提供了一种灵活的融资渠道,使其能够根据市场状况和资金需求,适时进行股权融资。

此次协议的签署,反映了Kyverna Therapeutics在资本运作方面的积极布局,旨在为公司的运营和未来发展提供资金支持。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10